Estapreg-H 250 Injection
Marketer
Estrellas Life Sciences Pvt. Ltd.
Salt Composition
Hydroxyprogesterone (250mg)
Overview Estapreg-H 250 Injection
Preterm labor prevention in pregnant women is facilitated by Estapreg-H 250 Injection, mitigating the likelihood of premature birth. It helps prevent miscarriage and subsequent preterm delivery in women with a history of premature births. Administration is strictly under a physician's direction, adhering to the prescribed dosage and duration. Treatment should continue as directed. Common side effects include injection site reactions, nausea, pruritus, diarrhea, and rash; these should be reported to your doctor for potential mitigation strategies. Blood glucose monitoring is crucial due to potential glycemic effects. Report jaundice, dark urine, or abdominal pain immediately. Prior to commencing treatment, disclose any history of circulatory problems, diabetes, liver disease, or other medications being used, as drug interactions may compromise efficacy or alter the drug's action.
Primary Ingredients of Estapreg-H 250 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Estapreg-H 250 Injection
Averting Preterm Birth
Major Benefits of Estapreg-H 250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Estapreg-H 250 Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Estapreg-H 250 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Estapreg-H 250 Injection works:
Estapreg-H 250 Injection contains a progestogen, a type of female sex hormone.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Estapreg-H 250 Injection is undetermined; therefore, physician consultation is advised before concurrent use.
PregnancySAFE IF PRESCRIBED
The injectable medication Estapreg-H 250 is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Human studies indicate that administration of Estapreg-H 250 Injection during lactation poses minimal risk. The medication shows negligible transfer into breast milk, suggesting it is unlikely to harm the infant.
DrivingSAFE
Driving ability is typically unaffected by Estapreg-H 250 Injection.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Estapreg-H 250 Injection's use in individuals with renal impairment. Physician consultation is advised. The drug's progesterone content may induce fluid retention in those with pre-existing kidney conditions.
LiverUNSAFE
Patients with liver impairment should likely avoid Estapreg-H 250 Injection due to potential safety concerns. Medical advice is recommended.
What if you forget to take Estapreg-H 250 Injection :
Should you forget a scheduled dose of Estapreg-H 250 Injection, seek your physician's advice.
Facts to Know About Estapreg-H 250 Injection
| Label | Value |
|---|---|
| Chemical Type | Glucocorticoids, Mineralocorticoids, and Progestin Derivatives |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
| Behavior Class | First-generation progestins |
3,018 People bought this recently